Skip to main content

Table 2 Anthropometric measurements of female participants on ART

From: The development of simple anthropometric measures to diagnose antiretroviral therapy-associated lipodystrophy in resource limited settings

Variable

Lipoatrophy*

P-value**

Lipohypertrophy***

P-value**

With n = 106 Median [IQR]

Without n = 312 Median [IQR]

With n = 142 Median [IQR]

Without n = 292 Median [IQR]

Height (m)

1.6 [1.5-1.6]

1.6 [1.5-1.6]

0.603

1.6 [1.6-1.6]

1.6 [1.5-1.6]

0.112

Weight (kg)

65.4 [56.0-74.5]

68.1 [58.9-80.9]

0.019

69.5 [60.7-80.4]

67.1 [57.6-79.3]

0.127

BMI

26.2 [23.8-29.3]

27.1 [24.1-31.6]

0.036

27.4 [24.6-31.3]

26.65 [23.9-31.2]

0.187

Sagittal Abdominal Diameter (cm)

20.5 [19.0-23.0]

20.0 [18.5-23.0]

0.552

21 [19–24]

20 [18–23]

0.004

Circumferences

      

  Waist (cm)

86.3 [79.5-96.3]

87.0 [78.5-97.0]

0.704

90.7 [80.3-98.5]

86 [78.4-95]

0.003

  Hip (cm)

98.0 [92.0-104.0]

102.0 [95.0-112.0]

<0.001

100 [95–110]

101 [94–110]

0.824

  Waist/hip ratio

0.90 [0.83-0.94]

0.85 [0.80-0.90]

<0.001

0.89 [0.83-0.93]

0.84 [0.79-0.90]

<0.001

  Mid-upper arm (cm)

27.0 [25.0-29.0]

29.0 [26.5-32.0]

<0.001

28 [26–32]

28 [26–32]

0.789

  Mid-thigh (cm)

54.5 [51.0-59.0]

57.0 [53.0-63.0]

<0.001

56 [52–61]

57[ 52–63]

0.589

Skinfolds

      

  Bicep (mm)

6.0 [4.4-8.4]

8.1 [5.7-11.7]

<0.001

7.1 [5.2-10.7]

8 [5.4-11.45]

0.189

  Tricep (mm)

13.3 [9.5-17.4]

18.4 [13.6-26.0]

<0.001

16.2 [12–22]

18.3 [13–25.15]

0.059

  Abdomen (mm)

20.4 [11.9-30.0]

24.4 [16.8-35.3]

0.001

24.1 [15.9-35.8]

23.6 [15.0-31.2]

0.210

  Thigh (mm)

23.8 [15.4-32.8]

34.7 [24.2-44.7]

<0.001

29.8 [20.5-42.5]

32.0 [22.5-43.5]

0.359

  Sub-Scapular (mm)

16.9 [12.5-23.0]

19.2 [12.2-28.8]

0.058

20 [14.8-29.4]

18.5 [11.7-27.1]

0.050

  Supra-iliac (mm)

13.2 [7.7-18.7]

15.1 [8.8-22.8]

0.033

16.6 [9.9-24.0]

13.9 [8.2-21.7]

0.022

  Calf (mm)

10.8 [8.0-17.5]

17.5 [12.2-24.2]

<0.001

15.6 [9.2-21.3]

17.3 [11.4-23.6]

0.061

  1. *based on patient report, those with moderate or severe fat loss in 2 or more regions.
  2. **Wilcoxon Rank-sum (Mann–Whitney) tests for continuous variables and chi-square tests for binary variables.
  3. ***based on patient report, those with moderate or severe fat gain in 2 or more regions.